| 21/62 | US=80 / Biol/Mol Brünner N, Holten-Andersen M, Sweep F, Foekens J, Schmitt M, Duffy MJ. New tumor biomarkers. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 189-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. BIOMARCADORES TUMORAIS; PRE-ANALITICA VARIAVEIS; VARIAVEL ANALITICA; POS-ANALITICA VARIAVEL; MARCADORES DE DETECCAO DE MARCADORES DE TRIAGEM; MARCADORES PROGNOSTICOS; MARCADORES PREDITIVOS; MARCADORES DE MONITORAMENTO |
| 22/62 | US=84 / Biol/Mol Hayashida T, Gupta V, Thiagalingam S, Maheswaran S. TGF-B superfamily members in normal and tumor biology: activins, inhibins, and bone morphogenetic proteins as modulators and biomarkers of prostate cancer progression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 355-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CANCER DE PROSTATA; ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 23/62 | US=111 / Câncer Vineis P. Molecular epidemiology of cancer and the use of biomarkers. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 410-9. ISBN 978-0-470-01852-1. CANCER; CANCER; EPIDEMIOLOGIA MOLECULAR; BIOMARCADORES; MARCADORES DE DOSE INTERNA; MARCADORES DE RESPOSTA TARDIA; PROTEOMICOS; EPIGENETICA; MARCADORES DE SUSCETIBILIDADE |
| 24/62 | US=84 / Câncer Hamdan MH. Overview. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 1-20. ISBN 978-0-471-74516-7. BIOMARCADORES DE CANCER; FASES DE DESENVOLVIMENTO DE BIOMARCADORES |
| 25/62 | US=84 / Câncer Hamdan MH. Proteomic platforms for biomarkrs discovery. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 21-112. ISBN 978-0-471-74516-7. PLATAFORMAS PROTEOMICAS; DESCOBERTA BIOMARKRS; BIOINFORMATICA EM SELDI; POLIACRILAMIDIA ELETROFORESE. GEL BIDIMENSIONAL; MICRODISSECCAO |
| 26/62 | US=84 / Câncer Hamdan MH. Some existing cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 113-62. ISBN 978-0-471-74516-7. BIOMARCADORES DE CANCER; DESSORCAO DE IONIZACAO; BIOINFORMATICA EM SELDI; MICRODISSECTION CAPTURA A LASER; PRETEIN MICRORRAYS; CROMATOGRAFIA LIQUIDA MULTIDIMENSIONAL |
| 27/62 | US=84 / Câncer Hamdan MH. Potential cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 163-248. ISBN 978-0-471-74516-7. POTENCIAIS BIOMARCADORES DE CANCER; CALICREINAS DE TECIDO HUMANO; FAMILIA DE PROTEINAS; PROTEINAS DE LIGACAO DE CALCIO |
| 28/62 | US=84 / Câncer Hamdan MH. Protein networks and protein phosphorylation in cancer. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 249-320. ISBN 978-0-471-74516-7. |
| 29/62 | US=84 / Câncer Hamdan MH. Ethical issues and initiatives relevant to cancer biomarkers. In: ___. Cancer biomarkers: analytical techniques for discovery. New Jersey: Jhon Wiley, 2007. p. 321-61. ISBN 978-0-471-74516-7. |
| 30/62 | US=2 / Mama Simon RM. General topics: guidelines for the design of clinical studies for the development and validation of therapeutically relevant biomarkers and biomarker-based classification systems. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 1-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; MICROARRAYS; SISTEMA DE CLASSIFICACAO; ENSAIOS CLINICOS |
| 31/62 | US=2 / Mama Sweep FCGJ, Thomas CMG, Schmitt M. General topics: analytical aspects of biomarker immunoassays in cancer research. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 17-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; IMUNOENSAIOS; MARCADORES TUMORAIS |
| 32/62 | US=2 / Mama Kim C, Paik S. General topics: tissue microarrays: state of the art, pitfalls, and promises. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 31-44. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; BIOMARCADORES; TISSUE MICROARRAYS; ENSAIOS CLINICOS MULTICENTRICOS; TISSUE ARRAY |
| 33/62 | US=2 / Mama De Bortoli M, Biglia N. Assays for gene expression and post-translational protein abnormalities: gene expression profiling with DNA microarrays: revolutionary tools to help diagnosis, prognosis, treatment guidance, and drug discovery. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 47-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; ENSAIOS DA EXPRESSAO DO GENE; ANORMALIDADES POS-TRADUCIONAIS; PERFIL DE EXPRESSAO GENICA; MICROARRANJOS DE DNA |
| 34/62 | US=2 / Mama Kim C, Song Y, Paik S. Assays for DNA abnormalities: assays for gene amplification. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 65-77. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. CANCER DE MAMA; ANOMALIAS DO DNA; ENSAIOS PARA AMPLIFICACAO DO GENE; TRASTUZUMABE; TESTE HER-2 |
| 35/62 | US=2 / Mama Daidone MG, Silvestrini R, Amadori D. Tissue predictive biomakers: cell kinetics. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 81-109. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES DE TECIDO PREDITIVOS; CINETICA CELULAR; PADRONIZACAO DO ENSAIO; ENSAIOS CLINICOS; VARIACOES POS-TRATAMENTO |
| 36/62 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: urokinase-type plasminogen activator and PAI-1. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 111-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; UROQUINASE; PLASMINOGENIO; PAI-1; CANCER; MARCADORES TUMORAIS; CANCER DE MAMA |
| 37/62 | US=2 / Mama Duffy MJ. Tissue predictive biomakers: predictive value of c-erb-B2 for endocrine therapy and chemotherapy in breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 129-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; VALOR PREDITIVO DE C-ERB-B2; HORMONIOTERAPIA; QUIMIOTERAPIA; CANCER DE MAMA; TRASTUZUMABE |
| 38/62 | US=2 / Mama Mass R. Tissue predictive biomakers: erb-B2 as a therapeutic target. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 159-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; ERB-B2; ALVO TERAPEUTICO; CANCER DE MAMA; HER2; TRASTUZUMABE; ANTICORPOS MONOCLONAIS |
| 39/62 | US=2 / Mama Ciardiello F, Troiani T, Tortora G. Tissue predictive biomakers: the epidermal growth factor receptor pathway as a selective molecular-targeted treatment in human breast cancer. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 177-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCAORES PREDITIVOS; FATOR DE CRESCIMENTO EPIDERMICO; VIA RECEPTOR; CANCER DE MAMA; EGF; EGFR |
| 40/62 | US=2 / Mama Kandioler D, Jakesk R. Tissue predictive biomakers: p53 as a prognostic and predicitive indicator. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 193-209. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. |